CRSR
Corsair Gaming, Inc.
CRSR has a slight edge over INTC overall, supported by lower modeled downside and stronger valuation.
INTC
Intel Corporation
INTC offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CRSR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CRSR's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
CRSR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $12.28 | — |
| Cheap | 18x | $7.00 | -43% |
| Fair | 30x | $11.35 | -7.5% |
| Current | 32x | $12.28 | — |
| Expensive | 99x | $37.59 | +206% |
Historical ranges are pointers, not guarantees.
CRSR's PE is in its fair range at 32x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
CRSR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CRSR, with profitability improving.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
CRSR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.79 | +107% |
| Q3 2026 | $0.38 | +$0.72 |
| Q2 2026 | $0.31 | +$1.12 |
| Q1 2026 | $0.09 | +$1.02 |
| Q4 2025 | -$0.12 | +$0.83 |
| Q3 2025 | -$0.34 | +$0.62 |
| Q2 2025 | -$0.81 | -$0.38 |
| Q1 2025 | -$0.93 | -$0.79 |
| Q4 2024 | -$0.95 | -$0.92 |
CRSR has the edge over INTC on earnings quality, reporting a profit while its opponent remains loss making.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
CRSR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $367M | +6.1% |
| Q2 2026 | $314.3M | -1.8% |
| Q1 2026 | $354.5M | -4.1% |
| Q4 2025 | $436.9M | +5.6% |
| Q3 2025 | $345.8M | +14% |
| Q2 2025 | $320.1M | +23% |
| Q1 2025 | $369.8M | +9.6% |
| Q4 2024 | $413.6M | -0.9% |
CRSR has the edge over INTC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +1.2 points |
| Q2 2026 | 2.4% | +7.7 points |
| Q1 2026 | 3.9% | +4.5 points |
| Q4 2025 | 6.2% | +4.7 points |
| Q3 2025 | -1.6% | +5.3 points |
| Q2 2025 | -5.3% | +4.2 points |
| Q1 2025 | -0.6% | +2.4 points |
| Q4 2024 | 1.4% | -1.5 points |
CRSR's operating margin was −0.5% last quarter, up 1.2 points from the same quarter a year ago.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over CRSR on profitability, with a higher operating margin.
CRSR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.7M | +$24.6M |
| Q2 2026 | $72.1M | +162% |
| Q1 2026 | $26.1M | +66% |
| Q4 2025 | $32.9M | -39% |
| Q3 2025 | -$41.3M | -290% |
| Q2 2025 | $27.5M | +$48.5M |
| Q1 2025 | $15.7M | +$44.5M |
| Q4 2024 | $54.1M | -1.9% |
CRSR usually generates cash, though not every quarter: the latest was −$17M, but it generated $114M over the past year.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over CRSR on cash flow, with more consistent year-over-year improvement.
CRSR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -487K shares |
| 1 year | +2.3% | +2.4M shares |
| 3 years | +5.7% | +5.8M shares |
| 5 years | +8.7% | +8.7M shares |
| Available history | +18% | +16.9M shares |
CRSR has the edge over INTC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $5M |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | $962,000 |
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has 5.3B diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
CRSR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -1.3x | Net Cash |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 1.5x | Healthy |
| Q2 2024 | 11.2x | High |
| Q1 2024 | 1.4x | Healthy |
| Q4 2023 | 0.4x | Very low |
| Q3 2023 | 1.3x | Healthy |
CRSR has the edge over INTC on leverage, with a lower net debt burden relative to earnings.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
CRSR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 40.1 | Neutral |
CRSR's weekly RSI is 55 (neutral) and its Stochastic is 40 (neutral).
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CRSR PE vs Technology Sector
| Metric | CRSR | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 28x | 16% above |
| PE % | 55 | 38 | 17 pts above |
CRSR is trading at 32x earnings, a 16% premium to the Technology sector's median of 28x.
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
CRSR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.0 | 5.8% below |
| 20 week MA | $12.2 | 1.1% above |
| 50 week MA | $8.83 | 39% above |
| 100 week MA | $8.67 | 42% above |
| 200 week MA | $10.8 | 14% above |
CRSR has the edge over INTC on trend strength, trading above more of its moving averages.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 44% above its 200-week average.
CRSR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.3 | $36.4 | +111% |
| 2021 | $36.4 | $22.4 | -38% |
| 2022 | $22.4 | $13.7 | -39% |
| 2023 | $13.7 | $14.1 | +2.6% |
| 2024 | $14.1 | $6.55 | -54% |
| 2025 | $6.55 | $6.10 | -6.9% |
| 2026 YTD | $6.10 | $12.3 | +101% |
CRSR has the edge over INTC on returns for 2026, with the stronger performance.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC is up 69% so far in 2026, after finishing lower in three of the previous six years.